Madoka Iida

1.1k total citations
41 papers, 847 citations indexed

About

Madoka Iida is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Genetics. According to data from OpenAlex, Madoka Iida has authored 41 papers receiving a total of 847 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 23 papers in Cellular and Molecular Neuroscience and 14 papers in Genetics. Recurrent topics in Madoka Iida's work include Genetic Neurodegenerative Diseases (19 papers), Muscle Physiology and Disorders (14 papers) and Neurogenetic and Muscular Disorders Research (14 papers). Madoka Iida is often cited by papers focused on Genetic Neurodegenerative Diseases (19 papers), Muscle Physiology and Disorders (14 papers) and Neurogenetic and Muscular Disorders Research (14 papers). Madoka Iida collaborates with scholars based in Japan, United States and Brazil. Madoka Iida's co-authors include Masahisa Katsuno, Gen Sobue, Hiroaki Adachi, Naohide Kondo, Genki Tohnai, Kei Ando, N. Saito, I Sobue, M Konagaya and Yu Miyazaki and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Nature Communications.

In The Last Decade

Madoka Iida

37 papers receiving 834 citations

Peers

Countries citing papers authored by Madoka Iida

Since Specialization

Citations

This map shows the geographic impact of Madoka Iida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Madoka Iida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Madoka Iida more than expected).

Fields of papers citing papers by Madoka Iida

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Madoka Iida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Madoka Iida. The network helps show where Madoka Iida may publish in the future.

Co-authorship network of co-authors of Madoka Iida

This figure shows the co-authorship network connecting the top 25 collaborators of Madoka Iida. A scholar is included among the top collaborators of Madoka Iida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Madoka Iida. Madoka Iida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An acyclic nucleic acid-modified siRNA targeting CAG expansions for polyglutamine disease treatment 2025 ·Molecular Therapy — Nucleic Acids ·(unknown), (unknown), Kentaro Sahashi, Yukiko Kamiya, Madoka Iida, Kenji Sakakibara, (unknown), Manabu Ohyama, Yohei Okada, Hideyuki Okano, Hiroyuki Asanuma, Masahisa Katsuno	0
2	Dysregulation of Aldh1a2 underlies motor neuron degeneration in spinal muscular atrophy 2023 ·Neuroscience Research ·(unknown), Kentaro Sahashi, (unknown), Jun‐ichi Takeda, (unknown), Madoka Iida, Masahisa Katsuno	3
3	Exercise attenuates polyglutamine‐mediated neuromuscular degeneration in a mouse model of spinal and bulbar muscular atrophy 2023 ·Journal of Cachexia Sarcopenia and Muscle ·(unknown), Hideaki Nakatsuji, Kentaro Sahashi, (unknown), Madoka Iida, Genki Tohnai, Naohide Kondo, Shinichiro Yamada, (unknown), (unknown), Hiroaki Adachi, Gen Sobue, Masahisa Katsuno	4
4	Mid1 is associated with androgen-dependent axonal vulnerability of motor neurons in spinal and bulbar muscular atrophy 2022 ·Cell Death and Disease ·Yosuke Ogura, Kentaro Sahashi, (unknown), Madoka Iida, Takaki Miyata, Masahisa Katsuno	5
5	Label-free morphological sub-population cytometry for sensitive phenotypic screening of heterogenous neural disease model cells 2022 ·Scientific Reports ·(unknown), Madoka Iida, Kei Kanie, Masahisa Katsuno, Ryuji Kato	4
6	Clinical implication of denervation in sporadic inclusion body myositis 2022 ·Journal of the Neurological Sciences ·(unknown), (unknown), (unknown), Satoko Hirano, (unknown), (unknown), Koji Matsuo, (unknown), Shinichiro Yamada, Madoka Iida, Haruki Koike, Satoshi Kuru, Masahisa Katsuno	3
7	Selective suppression of polyglutamine-expanded protein by lipid nanoparticle-delivered siRNA targeting CAG expansions in the mouse CNS 2021 ·Molecular Therapy — Nucleic Acids ·(unknown), Kentaro Sahashi, Kiyoshi Tachikawa, (unknown), Michelle Nguyen, Rajesh Mukthavaram, Priya Karmali, Padmanabh Chivukula, Genki Tohnai, Madoka Iida, (unknown), Manabu Ohyama, Yohei Okada, Hideyuki Okano, Masahisa Katsuno	27
8	Ratio of urinary N-terminal titin fragment to urinary creatinine is a novel biomarker for amyotrophic lateral sclerosis 2021 ·Journal of Neurology Neurosurgery & Psychiatry ·Shinichiro Yamada, Atsushi Hashizume, Yasuhiro Hijikata, Daisuke Ito, (unknown), Madoka Iida, Haruki Koike, Akihiro Hirakawa, Masahisa Katsuno	18
9	Neuroadaptations in the dorsal hippocampus underlie cocaine seeking during prolonged abstinence 2020 ·Proceedings of the National Academy of Sciences ·Craig Werner, Swarup Mitra, Benjamin D. Auerbach, Zi-Jun Wang, Jennifer A. Martin, Andrew F. Stewart, Pedro H. Gobira, Madoka Iida, (unknown), (unknown), Aaron Caccamise, Richard Salvi, Rachael L. Neve, Amy M. Gancarz, David Dietz	29
10	Elevated serum creatine kinase in the early stage of sporadic amyotrophic lateral sclerosis 2019 ·Journal of Neurology ·Daisuke Ito, Atsushi Hashizume, Yasuhiro Hijikata, Shinichiro Yamada, Yohei Iguchi, Madoka Iida, (unknown), (unknown), Akihiro Hirakawa, Masahisa Katsuno	24
11	Src inhibition attenuates polyglutamine-mediated neuromuscular degeneration in spinal and bulbar muscular atrophy 2019 ·Nature Communications ·Madoka Iida, Kentaro Sahashi, Naohide Kondo, Hideaki Nakatsuji, Genki Tohnai, Yutaka Tsutsumi, (unknown), (unknown), (unknown), Yohei Okada, Masahiro Nakatochi, (unknown), Shinobu Shimizu, Masaaki Mizuno, Hiroaki Adachi, Hideyuki Okano, Gen Sobue, Masahisa Katsuno	15
12	BIIB021, a synthetic Hsp90 inhibitor, induces mutant ataxin-1 degradation through the activation of heat shock factor 1 2016 ·Neuroscience ·Ying Ding, Hiroaki Adachi, Masahisa Katsuno, Kentaro Sahashi, Naohide Kondo, Madoka Iida, Genki Tohnai, Hideaki Nakatsuji, Gen Sobue	14
13	Silencing neuronal mutant androgen receptor in a mouse model of spinal and bulbar muscular atrophy 2015 ·Human Molecular Genetics ·Kentaro Sahashi, Masahisa Katsuno, Gene Hung, Hiroaki Adachi, Naohide Kondo, Hideaki Nakatsuji, Genki Tohnai, Madoka Iida, C. Frank Bennett, Gen Sobue	46
14	Overexpression of hepatocyte growth factor in SBMA model mice has an additive effect on combination therapy with castration 2015 ·Biochemical and Biophysical Research Communications ·Ying Ding, Hiroaki Adachi, Masahisa Katsuno, Zhe Huang, Yue‐Mei Jiang, Naohide Kondo, Madoka Iida, Genki Tohnai, Hideaki Nakatsuji, Hiroshi Funakoshi, Toshikazu Nakamura, Gen Sobue	5
15	Paeoniflorin eliminates a mutant AR via NF-YA-dependent proteolysis in spinal and bulbar muscular atrophy 2014 ·Human Molecular Genetics ·Genki Tohnai, Hiroaki Adachi, Masahisa Katsuno, Hideki Doi, (unknown), Naohide Kondo, Yu Miyazaki, Madoka Iida, Hideaki Nakatsuji, Qiang Qiang, Ying Ding, Hirohisa Watanabe, Masahiko Yamamoto, Kenzo Ohtsuka, Gen Sobue	30
16	Pioglitazone suppresses neuronal and muscular degeneration caused by polyglutamine-expanded androgen receptors 2014 ·Human Molecular Genetics ·Madoka Iida, Masahisa Katsuno, Hideaki Nakatsuji, Hiroaki Adachi, Naohide Kondo, Yu Miyazaki, Genki Tohnai, Kensuke Ikenaka, Hirohisa Watanabe, Masahiko Yamamoto, Ken Kishida, Gen Sobue	26
17	Heat shock factor-1 influences pathological lesion distribution of polyglutamine-induced neurodegeneration 2013 ·Nature Communications ·Naohide Kondo, Masahisa Katsuno, Hiroaki Adachi, Makoto Minamiyama, Hideki Doi, (unknown), Yu Miyazaki, Madoka Iida, Genki Tohnai, Hideaki Nakatsuji, Shinsuke Ishigaki, Yusuke Fujioka, Hirohisa Watanabe, Fumiaki Tanaka, Akira Nakai, Gen Sobue	44
18	Viral delivery of miR-196a ameliorates the SBMA phenotype via the silencing of CELF2 2012 ·Nature Medicine ·Yu Miyazaki, Hiroaki Adachi, Masahisa Katsuno, Makoto Minamiyama, Yue‐Mei Jiang, Zhe Huang, Hideki Doi, (unknown), Naohide Kondo, Madoka Iida, Genki Tohnai, Fumiaki Tanaka, Shin‐ichi Muramatsu, Gen Sobue	118
19	Naratriptan mitigates CGRP1-associated motor neuron degeneration caused by an expanded polyglutamine repeat tract 2012 ·Nature Medicine ·Makoto Minamiyama, Masahisa Katsuno, Hiroaki Adachi, Hideki Doi, Naohide Kondo, Madoka Iida, Shinsuke Ishigaki, Yusuke Fujioka, (unknown), Yu Miyazaki, Fumiaki Tanaka, Hiroki Kurihara, Gen Sobue	30
20	A novel MPZ mutation in Charcot–Marie–Tooth disease type 1B with focally folded myelin and multiple entrapment neuropathies 2011 ·Neuromuscular Disorders ·Madoka Iida, Haruki Koike, Tetsuo Ando, Makoto Sugiura, Masahiko Yamamoto, Fumiaki Tanaka, Gen Sobue	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact